Germany IVD Market Expected to Reach $5,453 million by 2023
The utilization of IVD techniques is expected to witness a significant rise with increasing diagnosis of diseases. Also, the IVD market has piqued the interest of healthcare industry owing to its high accuracy and precise techniques coupled with its wide range of applications across various disease indications.
Hemali Narkhede
Manager, Healthcare Research at AMR
According to a new report published by Allied Market Research, titled, Germany IVD Market by Product Type, Technique, Application, and End-User: Opportunity Analysis and Industry Forecast, 2017-2023, the Germany IVD market was valued at $3,727 million in 2016, and is projected to reach at $5,453 million by 2023, growing at a CAGR of 5.5% from 2017 to 2023. The immunodiagnostics segment accounted for more than one-third share of the total market in 2016.
Access Full Summary at: https://www.alliedmarketresearch.com/germany-IVD-market
In vitro diagnostics plays a vital role in the healthcare sector for early detection, diagnosis, and treatment of various diseases and disorders. Diseases such as infections, cancer, cardiovascular immunological, nephrological, and gastroenterological diseases are diagnosed in in vitro conditions. Incessant innovations in IVD product design and technological advancement have enabled to perform diagnostic test at home, which have encouraged patients to shift their focus from traditional medical methods to personalized medicines. Constant technological developments to improve efficacy of IVD, increase in geriatric population, rise in incidence and prevalence of infectious and chronic diseases, and increase in outsourcing of laboratories in Germany region drive the market growth. However, unfavorable reimbursement policies and stringent government regulations related to the safety and efficacy of the IVD are expected to restrain the market growth during the forecast period. Ongoing R&D associated with the IVD and increase in awareness of preventive healthcare measures provides huge growth potential for IVD market.
Based on product type, the reagents segment held the highest market share in 2016, owing to the recent introduction of new novel reagents in the market that are more effective.
Based on techniques, the immunodiagnostics segment contributed the highest market share in 2016, owing to the increase in prevalence of chronic and infectious diseases and rise in awareness of personalized medicine among the population.
Based on application, the infectious diseases segment contributed the highest market share in 2016, owing to the increase in prevalence of infectious diseases and rise in awareness of preventive health measures.
Based on end user, the standalone laboratory segment captured the highest market share in 2016, mainly due to wide availability of complex tests and high-tech infrastructure enabling fast and accurate test results.
Key Findings of the Germany IVD Market:
- The reagent segment dominated the market in 2016, and is projected to grow at the highest CAGR.
- The immunodiagnostics segment accounted for the highest share of one-third of total in 2016.
- The infectious diseases segment was the major shareholder in the Germany IVD based application market in 2016.
- The standalone laboratory segment accounted for the highest share of in 2016.
The major players profiled in the Germany IVD market are Thermo Fisher Scientific Inc., Alere Inc., Biomerieux, Danaher Corporation, F. Hoffmann-La Roche AG, Becton Dickinson and Company, Bio-Rad Laboratories, Bayer AG, Sysmex Corporation, and Johnson & Johnson among others.
Talk to David (Europe)
Talk to Sona Padman (Americas)
5933 NE Win Sivers Drive #205,
Portland, OR 97220 United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91 2066346060
Fax: +1(855) 550-5975
Ram D
Communications Officer
Allied Market Research
Contact Toll Free: +1-800-792-5285
Drop us an email at
media@alliedmarketresearch.com
Germany IVD Market by Product Type (Reagents, Instruments, and Software & Services), by Technique (Immunodiagnostics, Blood Testing, Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, and Other IVD Techniques), by Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, and Other Indications), and by End Users (Standalone Laboratory, Hospitals, Academic and Medical Schools, Point of Care Testing, and Others) - Opportunity Analysis and Industry Forecast, 2017-2023
Avenue: Entire Library membership of Allied Market Research Reports at your disposal
- Avenue is an innovative subscription-based online report database.
- Avail an online access to the entire library of syndicated reports on more than 2,000 niche industries and company profiles on more than 12,000 firms across 11 domains.
- A cost-effective model tailored for entrepreneurs, investors, and students & researchers at universities.
- Request customizations, suggest new reports, and avail analyst support as per your requirements.
- Get an access to the library of reports at any time from any device and anywhere.
Why Allied Market Research?
Infallible Methodology
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
Analyst Support
For complete satisfaction
Customization
On-demand customization of scope of the report to exactly meet your needs
Targeted Market View
Targeted market view to provide pertinent information and save time of readers
Featured Readings
Get Fresh content delivered
Get insights on topics that matter to your business. Stay updated on the area that interests you.
Buy Full Version
"Germany IVD Market"
Purchase Enquiry